Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen

Published:2022-03-31 Issue:1 Volume:57 Page:51-58
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Kim Su-In¹,Jung Sung-Hoon¹,Yhim Ho-Young²,Jo Jae-Cheol³,Song Ga-Young¹,Kim Mihee¹,Ahn Seo-Yeon¹,Ahn Jae-Sook¹,Yang Deok-Hwan¹,Kim Hyeoung-Joon¹,Lee Je-Jung¹

Affiliation:

1. Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Hwasun, Korea

2. Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Korea

3. Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

http://pdf.medrang.co.kr/BR/2022/057/BR057-01-51.pdf

Reference23 articles.

1. Multiple myeloma

2. Cancer Statistics, 2021

3. Patterns of Survival in Multiple Myeloma: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2003

4. Improved survival in multiple myeloma and the impact of novel therapies

5. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daratumumab Treatment for “Truly Frail” Elderly Myeloma Patients;Life;2024-03-15

2. Eastern Cooperative Oncology Group, β2-microglobulin, hemoglobin, and lactate dehydrogenase can predict early grade ≥ 3 infection in patients with newly diagnosed multiple myeloma: A real-world multicenter study;Frontiers in Microbiology;2023-01-27

3. Levofloxacin;Reactions Weekly;2022-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3